Company Overview
Double Wing Pharma Ltd is a Dissolved Private Limited Company.
Registered Address

Suite 501 Unit 2 94A Wycliffe Road, Northampton, NN1 5JF
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameDOUBLE WING PHARMA LTD
Company Number09538798
Registered Office AddressSuite 501 Unit 2 94a Wycliffe Road
 NN1 5JF
Company CategoryPrivate Limited Company
Company StatusDissolved
Country of OriginUnited Kingdom
Incorporation Date13/04/2015
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2019
Accounts Last Made Up Date31/12/2017
Accounts Account CategoryTOTAL EXEMPTION FULL
Returns Next Due Date11/05/2017
Returns Last Made Up Date13/04/2016
Directors & Members
Show Resigned
Jagjeet Ahluwalia - Director
(British, 64 years old, born November 1962)
Appointed 24 August 2016
 Active
Douglas Andrews - Director
(American, 75 years old, born May 1951)
Appointed 13 April 2015
 Active
Douglas Murdoch - Director
(British, 76 years old, born March 1950)
Appointed 13 April 2015
 Active
Anil Sharma - Director
(British, 74 years old, born July 1952)
Appointed 24 August 2016
 Active
Xiaoli Wang - Director
(Chinese, 57 years old, born February 1969)
Appointed 13 April 2015
 Active
Secretaries
No Secretaries Appointed
Other Company Directorships
Jagjeet Ahluwalia
ABHAYA INVESTMENTS LIMITED
ABHAYA PROPERTIES LIMITED
ASAP GROWTH LIMITED
EADANE LIMITED
KINEDEXE UK LIMITED
MEDSOLUTIONS (EUROPE) LIMITED
SD & J INVESTMENTS LIMITED
Douglas Andrews
AQUAPAK HYDROPOLYMERS LTD
DOUBLE WING HEALTH & BEAUTY LTD
DOUBLE WING PHARMA DEVELOPMENT LTD
MERCURIALI LIMITED
SEACROSS PHARMACEUTICALS LTD
SOLATUMFARMA LTD
STRAVENCON LIMITED
Douglas Murdoch
ADHARTAS HEALTHCARE ADVISORS LTD
DOUBLE WING PHARMA DEVELOPMENT LTD
SOLATUMFARMA LTD
Anil Sharma
ABHAYA CARE LIMITED
ABHAYA INVESTMENTS LIMITED
ABHAYA LIMITED
ASAP GROWTH LIMITED
AURELIAA GLOBAL LIMITED
BIOQUBE LIMITED
CONNAUGHT PLACE HOLDINGS LIMITED
CONNAUGHT PLACE SERVICES LIMITED
EADANE LIMITED
GATNEW LTD
INDOSS LIMITED
KINEDEXE UK LIMITED
KUBBERLAXMI LIMITED
L M MANUFACTURING LIMITED
LIQMEDS CRITICAL CARE LIMITED
LIQMEDS LIFECARE LIMITED
LIQMEDS LIFESCIENCES LIMITED
LIQMEDS LIMITED
LIQMEDS WORLDWIDE LIMITED
MED SURGE LTD
MEDSOLUTIONS (EUROPE) LIMITED
NATLIP LIMITED
NRIM OVERSEAS INVESTMENTS LIMITED
PRIMEGEN LIFE SCIENCES (UK) LIMITED
SOLATUMFARMA LTD
SUNWAYS RENEWABLE PARTNERS LIMITED
UDAG (NO.2) LIMITED
UDAJ LIMITED
UDAK LIMITED
UDANE LIMITED
UDAYA PROPERTIES AYLESFORD LIMITED
UDAYA REALITIES LIMITED
UDN REDEVELOPMENTS LTD
WEST SUNDERLAND INVESTMENTS LIMITED
Xiaoli Wang
DOUBLE WING HEALTH & BEAUTY LTD
DOUBLE WING PHARMA DEVELOPMENT LTD
SOLATUMFARMA LTD
Balance Sheet Unlock full report
Accounts Date 31-Dec-2017 30-Apr-2016
Balance Sheet
Fixed Assets 0 0
Current Assets 1,178 1,178
Creditors Due Within One Year 8,109 8,109
Working Cap 9,287 9,287
Total Assets Less Current Liabilities -6,931 -6,931
Long-term Liabilities 0 0
Net Assets -6,931 -6,931
Share Capital & Reserves
Share Cap 3 3
Profit & Loss Reserves -6,934 -6,934
Other Reserves 0 0
Shareholders Funds -6,931 -6,931
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2017 30-Apr-2016
Tangible Fixed Assets - -
Fixed Assets 0.0% 0.0%
Stocks Inventory - -
Debtors 99.7% 99.7%
Cash Bank In Hand 0.3% 0.3%
Current Assets 100.0% 100.0%
Creditors Due Within One Year 688.4% 688.4%
Net Current Assets Liabilities - -
Creditors Due After One Year - -
Accruals Deferred Income - -
Provisions For Liabilities Charges - -
Net Assets Liabilities Including Pension Asset Liability - -
Called Up Share Capital 0.3% 0.3%
Share Capital Allotted Called Up Paid 0.3% 0.3%
Profit Loss Account Reserve -588.6% -588.6%
Shareholder Funds -588.4% -588.4%
Capital Employed - -
Total Assets Less Current Liabilities -588.4% -588.4%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2017 30-Apr-2016
Liquidity Ratio 0.1 0.1
Solvency Ratio 0.1 0.1
Reserves to Assets -5.9 -5.9
Secured Creditors Unlock full report
Mortgages Charges 1
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 1
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2017 30-Apr-2016
Assets 1,178 1,178
Debt 8,109 8,109
Net Assets/Debt -6,931 -6,931
Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around NN1 5JF
LEYLAND PACKAGING LIMITED
UNIT 21 ROTHERSTHORPE CRESCENT, ROTHERSTHORPE INDUSTRIAL ESTATE, NORTHAMPTON, NORTHAMPTONSHIRE, NN1 5JF
HEELEY-ALDEN LIMITED
38-40 WYCLIFFE ROAD, NORTHAMPTON, NN1 5JF
BRITISH NATURISM
4 Pavillion Court, 600 Pavilion Drive, Northampton, NN1 5JF
ALFRED TEAR FINE FURNITURE LIMITED
34-36 Wycliffe Road, Northampton, NN1 5JF
Document Filings
Final Gazette dissolved following liquidation
Return of final meeting in a Members' voluntary winding up
Registered office address changed from 1 King's Avenue Winchmore Hill London N21 3NA to Suite 501 Unit 2 94a Wycliffe Road Northampton NN1 5JF on 19 July 2024
Liquidators' statement of receipts and payments to 2 June 2023
Liquidators' statement of receipts and payments to 2 June 2022
Liquidators' statement of receipts and payments to 2 June 2021
Liquidators' statement of receipts and payments to 2 June 2020
Registered office address changed from Portwall Place Portwall Lane Bristol BS1 6NA United Kingdom to 1 King's Avenue Winchmore Hill London N21 3NA on 24 June 2019
Declaration of solvency
Appointment of a voluntary liquidator
Resolutions
Satisfaction of charge 095387980001 in full
Statement of capital following an allotment of shares on 11 January 2019
Termination of appointment of Paul Stuart Sturgeon as a director on 30 September 2018
Registration of charge 095387980001, created on 1 June 2018
Confirmation statement made on 13 April 2018 with updates
Statement of capital following an allotment of shares on 18 August 2017
Previous accounting period shortened from 30 April 2017 to 31 December 2016
Director's details changed for Mr Douglas Bruce Andrews on 22 June 2017
Director's details changed for Mr Douglas Bruce Murdoch on 22 June 2017
Appointment of Mr Paul Stuart Sturgeon as a director on 26 May 2017
Confirmation statement made on 13 April 2017 with updates
Registered office address changed from 454/458 Chiswick High Road London W4 5TT United Kingdom to Portwall Place Portwall Lane Bristol BS1 6NA on 10 May 2017
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free